The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Platelet Activation With Unfractionated Heparin at Therapeutic Concentrations and Comparisons With a Low-Molecular-Weight Heparin and With a Direct Thrombin Inhibitor
Abstract
Background —The growing use of heparin in acute thrombotic disorders, coupled with the availability of many new antithrombotic agents, emphasizes the need for adequate characterization of the platelet effects of the various anticoagulants. Controversial platelet effects have been reported with heparin (eg, enhanced platelet activation in vitro with high doses and no such effect in vivo at therapeutic doses). This study examined platelet receptor activation and platelet aggregation at therapeutic concentrations of unfractionated heparin (UFH), of enoxaparin, a low-molecular-weight heparin, and of argatroban, a direct thrombin inhibitor. Methods and Results —Platelet P-selectin (CD62) and activated GP IIb/IIIa (PAC-1) expression on platelet membrane was quantified in whole blood as well as platelet aggregation in platelet-rich plasma in 43 patients with unstable angina before and during treatment with UFH or enoxaparin. Studies were also carried out in blood of seven normal volunteers after addition ex vivo of UFH (0.25 U/mL), enoxaparin (0.25 U/mL), argatroban (1 ng/mL), and normal saline. UFH in patients with unstable angina increased the percentage of circulating platelets positive to PAC-1 from 2.7±1.7% to 4.4±3.4% ( P <.05) and to CD62 from 1.6±0.9% to 2.7±1.5% ( P <.01). Platelets were also hyperresponsive to stimulation with ADP and with the thrombin-receptor agonist peptide. Aggregation to ADP increased from 6.8±4.6% to 11.2±7.0% and to TRAP from 5.2±3.5% to 11.1±6.0% ( P <.001). The addition of UFH to blood of normal volunteers resulted also in activation of GP IIb/IIIa receptors, expression of P-selectin, and enhanced platelet aggregation. Enoxaparin had only minor effects on platelet activation in vivo and ex vivo, and argatroban, evaluated ex vivo, had no detectable effects. Conclusions —Therapeutic concentrations of UFH are associated with platelet activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Platelet Activation in Unstable Coronary Disease
Fitzgerald, D. J., Roy, L., Catella, F., & FitzGerald, G. A. (1986) · New England Journal of Medicine · doi:10.1056/nejm198610163151602 · Cited by 1,141
Weitz, J. I., Hudoba, M., Massel, D., Maraganore, J., & Hirsh, J. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114723 · Cited by 1,123
Tofler, G. H., Brezinski, D., Schafer, A. I., Czeisler, C. A., Rutherford, J. D., Willich, S. N., Gleason, R. E., Williams, G. H., & Muller, J. E. (1987) · New England Journal of Medicine · doi:10.1056/nejm198706113162405 · Cited by 1,072
Hirsh, J., & Levine, M. (1992) · Blood · doi:10.1182/blood.v79.1.1.bloodjournal7911 · Cited by 894
Shattil, S., Cunningham, M., & Hoxie, J. (1987) · Blood · doi:10.1182/blood.v70.1.307.307 · Cited by 756
Effect of Heparin and Heparin Fractions on Platelet Aggregation
Salzman, E. W., Rosenberg, R. D., Smith, M. H., Lindon, J. N., & Favreau, L. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109661 · Cited by 591
Reactivation of Unstable Angina after the Discontinuation of Heparin
Théroux, P., Waters, D., Lam, J., Juneau, M., & McCans, J. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207163270301 · Cited by 464
A monoclonal antibody to a membrane glycoprotein binds only to activated platelets.
McEver, R. P., & Martin, M. N. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42770-0 · Cited by 447
Hsu-Lin, S., Berman, C. L., Furie, B. C., August, D., & Furie, B. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)47274-7 · Cited by 421
Bleeding associated with antithrombotic therapy.
Jg, K., & Hirsh, J. (1980) · PubMed · Cited by 147
Hemorrhagic doses of heparin and other glycosaminoglycans induce a platelet defect
Fernandez, F., Nguyên, P., van Ryn, J., Ofosu, F. A., Hirsh, J., & Buchanan, M. R. (1986) · Thrombosis Research · doi:10.1016/0049-3848(86)90094-0 · Cited by 139
The Potentiation of Platelet Aggregation and Adhesion by Heparin in Vitro and in Vivo
Thomson, C. L., Forbes, C. D., & Prentice, C. R. M. (1973) · Clinical Science · doi:10.1042/cs0450485 · Cited by 134
Circadian variation of plasma fibrinopeptide A level in patients with variant angina.
Ogawa, H., Yasue, H., Oshima, S., Okumura, K., Matsuyama, K., & Obata, K. (1989) · Circulation · doi:10.1161/01.cir.80.6.1617 · Cited by 123
Impairment by Heparin of Primary Haemostasis and Platelet [14C]5‐Hydroxytryptamine Release
Heiden, D., Mielke, C. H., & Rodvien, R. (1977) · British Journal of Haematology · doi:10.1111/j.1365-2141.1977.tb00666.x · Cited by 117
Holmer, E., Lindahl, U., Bäckström, G., Thunberg, L., Sandberg, H., Soderstrom, G. F., & Andersson, L.-O. (1980) · Thrombosis Research · doi:10.1016/0049-3848(80)90208-x · Cited by 107
Characterization of platelet binding of heparins and other glycosaminoglycans
Sobel, M., & Adelman, B. (1988) · Thrombosis Research · doi:10.1016/0049-3848(88)90341-6 · Cited by 77
Hjemdahl, P., Chronos, N., Wilson, D. J., et al. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.1.77 · Cited by 75
Inhibition of Thrombin Induced Aggregation of Human Platelets by Heparin
Eika, C. (1971) · Scandinavian Journal of Haematology · doi:10.1111/j.1600-0609.1971.tb01976.x · Cited by 67
Haemostatic variables in patients with unstable angina
Al-Nozha, M. M., Gader, A. M. A., Al-Momen, A. K. M., Noah, M. S., Jawaid, M., & Arafa, M. (1994) · International Journal of Cardiology · doi:10.1016/0167-5273(94)90207-0 · Cited by 28
Melina, G., Colivicchi, F., Bevilacqua, E., Magnanimi, S., & Melina, D. (1995) · Clinical and Experimental Hypertension · doi:10.3109/10641969509037400 · Cited by 6
Cited by
Braunwald, E., Antman, E. M., Beasley, J. W., Califf, R. M., Cheitlin, M. D., Hochman, J. S., Jones, R. H., Kereiakes, D., Kupersmith, J., Levin, T. N., et al. (2000) · Circulation · doi:10.1161/01.cir.102.10.1193 · Cited by 4,487
Self-citationAnderson, J. L., Adams, C. D., Antman, E. M., Bridges, C. R., Califf, R. M., Casey, D. E., Chavey, W. E., Fesmire, F. M., Hochman, J. S., Levin, T. N., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.181940 · Cited by 1,853
Self-citationAnderson, J. L., Adams, C. D., Antman, E. M., Bridges, C. R., Califf, R. M., Casey, D. E., Chavey, W. E., Fesmire, F. M., Hochman, J. S., Levin, T. N., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.02.013 · Cited by 1,510
Self-citationLincoff, A. M., Bittl, J. A., Harrington, R. A., Feit, F., Kleiman, N. S., Jackman, J. D., Sarembock, I. J., Cohen, D. J., Spriggs, D., Ebrahimi, R., et al. (2003) · JAMA · doi:10.1001/jama.289.7.853 · Cited by 1,162
Braunwald, E., Antman, E. M., Beasley, J. W., Califf, R. M., Cheitlin, M. D., Hochman, J. S., Jones, R. H., Kereiakes, D., Kupersmith, J., Levin, T. N., et al. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00889-5 · Cited by 963
Self-citation
Metadata
- Authors
- Xiao, Z., & Théroux, P.
- Venue
- Circulation
- Published
- 1998-01-27
- Volume
- 97
- Issue
- 3
- Pages
- 251-256
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2052443929
- Cited by
- 382
- References
- 20
- FWCI
- 15.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.